Topical medication cost and utilization continue to decrease in the managed population. However, in the unmanaged space we continue to see year-over-year increases in both cost and utilization. Understanding the differences in the types of topical medications dominating each space can help us to target pharmaceutical management strategies that weed out price opportunists and ensure the most appropriate care. View the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Diagnostics Platform Surpasses 3 Million Scans
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Mitchell
News Release
Mitchell Named Official Technology Provider of the Vale Paintless Dent Repair (PDR) Technician Certification Program
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).
PDF
Article
Specialty Services Are a Big Deal
When adjusters have to jump through hoops to make referrals, they lose precious time.
Mitchell
Virtual Event
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In
On-Demand
On July 2, 2021, Michigan’s new auto fee schedule went into effect for services rendered on or after that date.